Stocks and Investing Stocks and Investing
Tue, January 25, 2022
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (VTEX) at Buy with Decreased Target to $10 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Justin Jenkins Maintained (VLO) at Strong Buy with Increased Target to $100 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ryan Todd Maintained (VLO) at Buy with Increased Target to $95 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Durgesh Chopra Upgraded (XEL) to Buy and Increased Target to $75 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Peter Sazel Initiated (TWLO) at Buy and Held Target at $240 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Faucette Maintained (TRMB) at Sell with Decreased Target to $70 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (TOST) at Buy with Decreased Target to $30 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Dan Dolev Maintained (TOST) at Hold with Decreased Target to $24 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
George Hill Maintained (TDOC) at Hold with Decreased Target to $81 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Spiro Dounis Maintained (SUN) at Hold with Increased Target to $42 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Christopher Kapsch Initiated (SQM) at Strong Buy and Held Target at $102 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Dan Dolev Maintained (SQ) at Strong Buy with Decreased Target to $210 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (SQSP) at Buy with Decreased Target to $35 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (SRE) at Hold with Decreased Target to $77 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Schappel Upgraded (SNOW) to Strong Buy and Held Target at $370 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Durgesh Chopra Upgraded (SO) to Hold and Held Target at $66 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Long Maintained (ZION) at Strong Buy with Increased Target to $80 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Goodall Downgraded (AAL) to Hold on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
George Hill Maintained (AGL) at Strong Buy with Decreased Target to $29 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Dan Dolev Maintained (AFRM) at Strong Buy with Decreased Target to $100 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Josh Beck Maintained (BIGC) at Buy with Decreased Target to $40 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Suneet Kamath Maintained (AFL) at Hold and Held Target at $61 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Durgesh Chopra Maintained (AEP) at Buy with Increased Target to $102 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Argento Initiated (ARLO) at Strong Buy and Held Target at $14 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sumeet Mody Initiated (ARES) at Buy and Held Target at $97 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Devin McDermott Maintained (AR) at Hold with Decreased Target to $25 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sanjit Singh Maintained (APPN) at Hold with Decreased Target to $55 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Freeman Maintained (APA) at Strong Buy with Increased Target to $53 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Devin McDermott Maintained (APA) at Buy with Increased Target to $41 on, Jan 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bradley Canino Upgraded (BPMC) to Strong Buy and Decreased Target to $95 on, Jan 25th, 2022

Bradley Canino Upgraded (BPMC) to Strong Buy and Decreased Target to $95 on, Jan 25th, 2022


Published on 2024-10-27 19:24:43 - WOPRAI, Bradley Canino
  Print publication without navigation


Bradley Canino of Stifel, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy and Decreased Target from $120 to $95 on, Jan 25th, 2022.

Bradley has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Bradley's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Friday, October 29th, 2021


These are the ratings of the 3 analyists that currently disagree with Bradley

  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $120 on, Wednesday, January 12th, 2022
  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Monday, January 3rd, 2022
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $133 on, Wednesday, November 10th, 2021

Contributing Sources